Literature DB >> 16378743

Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.

Raphael Schiffmann1, Orna Elroy-Stein.   

Abstract

Mutations in eukaryotic initiation factor 2B (eIF2B) cause one of the most common leukodystrophies, childhood ataxia with CNS hypomyelination/vanishing white matter disease or CACH/VWM. Patients may develop a wide spectrum of neurological abnormalities from prenatal-onset white matter disease to juvenile or adult-onset ataxia and dementia, sometimes with ovarian insufficiency. The pattern of diffuse white matter abnormalities on MRI of the head is often diagnostic. Neuropathological abnormalities indicate a unique and selective disruption of oligodendrocytes and astrocytes with sparing of neurons. Marked decrease of asialo-transferrin in cerebrospinal fluid is the only biochemical abnormality identified thus far. Eukaryotic translation initiation factor 2B (eIF2B) mutations cause a decrease in guanine nucleotide exchange activity on eIF2-GDP, resulting in increased susceptibility to stress and enhanced ATF4 expression during endoplasmic reticulum stress. eIF2B mutations are speculated to lead to increased susceptibility to various physiological stress conditions. Future research will be directed towards understanding why abnormal control of protein translation predominantly affects brain glial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378743     DOI: 10.1016/j.ymgme.2005.10.019

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

1.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

2.  A Unique ISR Program Determines Cellular Responses to Chronic Stress.

Authors:  Bo-Jhih Guan; Vincent van Hoef; Raul Jobava; Orna Elroy-Stein; Leos S Valasek; Marie Cargnello; Xing-Huang Gao; Dawid Krokowski; William C Merrick; Scot R Kimball; Anton A Komar; Antonis E Koromilas; Anthony Wynshaw-Boris; Ivan Topisirovic; Ola Larsson; Maria Hatzoglou
Journal:  Mol Cell       Date:  2017-12-07       Impact factor: 17.970

3.  Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?

Authors:  Peter Hoch-Kraft; Jacqueline Trotter; Constantin Gonsior
Journal:  Neurochem Res       Date:  2019-03-06       Impact factor: 3.996

4.  Episodic hemiparesis precipitated by trauma.

Authors:  Ananthanarayanan Kasinathan; Hansashree Padmanabha; Renu Suthar; Naveen Sankhyan
Journal:  Childs Nerv Syst       Date:  2020-01-15       Impact factor: 1.475

5.  Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.

Authors:  Irit Gat-Viks; Tamar Geiger; Mali Barbi; Gali Raini; Orna Elroy-Stein
Journal:  J Neurochem       Date:  2015-05-14       Impact factor: 5.372

6.  An adolescence-onset male leukoencephalopathy with remarkable cerebellar atrophy and novel compound heterozygous AARS2 gene mutations: a case report.

Authors:  Qing Dong; Ling Long; Yan-Yu Chang; Yan-Jun Lin; Mei Liu; Zheng-Qi Lu
Journal:  J Hum Genet       Date:  2018-04-17       Impact factor: 3.172

Review 7.  Endoplasmic reticulum stress in disorders of myelinating cells.

Authors:  Wensheng Lin; Brian Popko
Journal:  Nat Neurosci       Date:  2009-03-15       Impact factor: 24.884

8.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

9.  Role of Saccharomyces cerevisiae TAN1 (tRNA acetyltransferase) in eukaryotic initiation factor 2B (eIF2B)-mediated translation control and stress response.

Authors:  Sonum Sharma; Anuradha Sourirajan; Kamal Dev
Journal:  3 Biotech       Date:  2017-07-04       Impact factor: 2.406

Review 10.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.